High Containment Collaboration ProImmune recently announced a collaboration with UTMB Galveston National Laboratory to develop tools for high containment infectious diseases, demonstrating proven capability to support high biosafety projects and offering a ready path for specialized immune monitoring reagents and assays for BSL3 and BSL4 research.

Adaptive Immunity Platform The company provides an integrated antigen characterization platform with tracking of antigen specific responses using ELISpot and flow cytometry, enabling preclinical and clinical immunology studies and creating cross sell opportunities for end to end assay development and workflow services.

European Growth Channel Headquartered in Oxford and operating as a mid sized immunology specialist, ProImmune is well positioned to partner with European biotech, CROs, and academic labs seeking reliable reagents, custom assays, and immune monitoring services.

Infectious Disease Tooling Recent news highlights ongoing expansion into tools for studying infectious diseases, signaling demand for innovative reagents and platform capabilities that can be offered to partners pursuing disease surveillance, vaccine and therapeutic research.

Customer Growth Potential With modest revenue scale and strategic collaborations, there is opportunity to grow through long term service agreements, recurring reagent supply, and joint development projects with pharma, biotech startups and academia.